MACS
LIVE

Serial Number

79152214

Owner

MILTENYI BIOTEC B.V. & CO. KG

Attorney

Peter S. Sloane

Filing Date

Mar 14, 2014

Add to watchlist:

No watchlists yet
View on USPTO

MACS Trademark

Serial Number: 79152214 • Registration: 4853118

MACS is a trademark filed by MILTENYI BIOTEC B.V. & CO. KG on March 14, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Miltenyi Biotec GmbH (30 trademarks)

Friedrich-Ebert-Strabe 68
51429 Bergisch Gladbach , DE

Entity Type: 03

Trademark Details

Filing Date

March 14, 2014

Registration Date

November 17, 2015

Published for Opposition

September 1, 2015

Goods & Services

Apparatus for magnetic cell separation for medical purposes for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tube sets composed of blood collecting tube or drainage tubes for medical purposes; analysis columns for medical purposes, for blood analysis; cell culture apparatus for medical use, namely, cell culture sacks, pouches, bags, films, tubes and connecting pieces for cryopreservation; instruments and apparatus for medical purposes for use in surgery and medical diagnosis and therapy, namely, instruments for the medical diagnosis in the fields of cancer or other tissue-based diseases as well as cytology and other cell-based diseases; accessories and replacement parts for the aforesaid goods, namely, medical guide wires and parts and fittings therefor

Scientific and technological services, namely, scientific, research, analysis and testing in the field of cell separation and isolation; Scientific and technological services, namely, research and design in the field of biotechnology; industrial research in the field of histology; design and development of computer hardware and software for analysis; all of the aforesaid services for and in connection with the analysis of biological and biochemical material, in particular of cell material for biological and medical research and therapy; medical, pharmaceutical and biotechnological research laboratories services

Chemical, biological and biochemical preparations for industrial, scientific and diagnostic purposes, other than for medical purposes, namely, chemical preparations for use in industry and biological preparation for use in cell cultures other than for medical or veterinary use; chemical products, namely, chemical additives for use in separation processes for biological materials; biochemical, chemical and diagnostic reagents for cell separation for scientific purposes, labelling biochemical, chemical and diagnostic reagents for scientific use; reagents, namely, biochemical, chemical and diagnostic reagents for non-medical purposes; media, namely, cell culture media for growing cells for use in scientific research; substances and constituent parts, namely, cytokines and growth factors, small molecules, proteins and serum fractions, for preparing media, all being used in industry and science and for use in medical laboratories; biochemical, chemical and diagnostic reagents for non-medical purposes for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemical and biological material; biochemical, chemical and diagnostic reagents for non-medical purposes featuring magnetic beads; antibody biochemical, chemical and diagnostic reagents other than for medical or veterinary purposes; buffer solutions and biochemical, chemical and diagnostic reagents for non-medical purposes for use with laboratory apparatus, in particular separation apparatus, analysis apparatus, reactors and imaging apparatus; biochemical, chemical and diagnostic reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof other than for medical or veterinary purposes, namely, buffer solutions for passaging, processing and storing of cells, cell stimulating and modifying agents such as antigens, peptides and nucleotides, extracellular matrices and carrier materials for cell culture; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, contrast media, contrast media for in-vivo imaging, all being for scientific research purposes; biochemical and chemical and diagnostic reagents for use in biotechnology, biological processing operations and the biotechnological industry for non-medical purposes

Pharmaceutical, medical and veterinary preparations and preparations for pharmaceutical, medical and veterinary science, namely, diagnostic preparations for medial and veterinary use for the purpose of early recognition or characterization of diseases; pharmaceutical and other preparations, namely, diagnostic preparations for medial and veterinary use for the purpose of early recognition or characterization of diseases; reagents, media, substances in the nature of buffering solutions and components in the nature of growth factors, vitamins, and other additives for the preparation of media, all for medical or veterinary diagnostic use; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of biological material, all being for medical or veterinary diagnostic purposes; reagents featuring magnetic beads, antibody reagents, all being for medical or veterinary diagnostic purposes; buffer solutions in the nature of physiological salt solutions and for medical diagnostics; medical diagnostic reagents for use with medical apparatus, in particular separation apparatus, analyzing apparatus, reactors and imaging apparatus; medical diagnostic reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, all being for medical or veterinary purposes; diagnostic preparations and reagents for medical and veterinary use; culture media for use in cultivation and maturation of stem cells, tissue cells, or immune cells for medical purposes; cell culture media for cultivating microorganism, freezing media for use in in-vitro fertilization consisting primarily of sperm freezing medium and to store blood products, contrast media for use with cytometry equipment, and contrast media for in-vivo imaging, all being for medical and veterinary purposes; pharmaceutical preparations, in particular pharmaceutical preparations for cellular therapy treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases as well as in the field of immunology, dermatology, neuroscience and cardiovascular research; chemical, biological and biochemical preparations for therapeutic treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases as well as in the field of immunology, dermatology, neuroscience and cardiovascular research

Scientific apparatus and instruments, namely, spectrometers, apparatus and columns for the automated cell separation and isolation, cytometry instruments; optical apparatus and instruments, namely, optical mirrors and screening apparatus in the nature of a device to screen data resulting from cell separation processes for the purpose of further cell analysis consisting of a microscope, a lens and a display; measuring apparatus and instruments, namely, digitizers; apparatus for recording, transmission or reproduction of images; data processing apparatus; computer software for controlling and managing of blood and blood elements information; all of the aforesaid goods, solely for the separation and analysis of biological material; scientific, electric and electronic apparatus and instruments, namely, laboratory chemical reactors for conducting enzymatic reactions; laboratory apparatus, in particular cytometers for measuring the physical and chemical properties of cells and particles in suspensions; instruments and apparatus for biotechnological and scientific purposes, namely, chromatography columns for use in purification in the laboratory for use in the analysis of biological material; all of the foregoing not used in the oil and gas industry

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 28, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Oct 28, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 20, 2025 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2025 REAP
TEAS SECTION 71 RECEIVED
Jul 1, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 18, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 4, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 14, 2022 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 14, 2022 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 11, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Oct 28, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 17, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 20, 2020 NREP
CHANGE OF OWNER RECEIVED FROM IB
Dec 5, 2019 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 26, 2016 FICS
FINAL DISPOSITION PROCESSED
Apr 26, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 17, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 17, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2015 NPUB
PUBLISHED FOR OPPOSITION
Sep 1, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Aug 28, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 12, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 12, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 24, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 21, 2015 XAEC
ASSIGNED TO LIE
Jul 21, 2015 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 21, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 21, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 21, 2015 CNEA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 6, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 6, 2015 GNSL
SUSPENSION LETTER WRITTEN
Apr 6, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2015 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2014 RFNT
APPLICATION FILING RECEIPT MAILED
Oct 3, 2014 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2014 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2014 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 29, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 18, 2014 REPR